Home > Publications database > Intentions of Patients With Cancer and Their Relatives to Use a Live Chat on Familial Cancer Risk: Results From a Cross-Sectional Web-Based Survey. > print

001     282370
005     20240918105537.0
024 7 _ |a 10.2196/45198
|2 doi
024 7 _ |a pmid:37639311
|2 pmid
024 7 _ |a 1439-4456
|2 ISSN
024 7 _ |a 1438-8871
|2 ISSN
024 7 _ |a altmetric:153398885
|2 altmetric
037 _ _ |a DKFZ-2023-01752
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Memenga, Paula
|0 0000-0001-5067-0430
|b 0
245 _ _ |a Intentions of Patients With Cancer and Their Relatives to Use a Live Chat on Familial Cancer Risk: Results From a Cross-Sectional Web-Based Survey.
260 _ _ |a Richmond, Va.
|c 2023
|b Healthcare World
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726649717_8429
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:M100#
520 _ _ |a An important prerequisite for actively engaging in cancer prevention and early detection measures, which is particularly recommended in cases of familial cancer risk, is the acquisition of information. Although a lot of cancer information is available, not all social groups are equally well reached because information needs and communicative accessibility differ. Previous research has shown that a live chat service provided by health professionals could be an appropriate, low-threshold format to meet individual information needs on sensitive health topics such as familial cancer risk. An established German Cancer Information Service is currently developing such a live chat service. As it is only worthwhile if accepted by the target groups, formative evaluation is essential in the course of the chat service's development and implementation.This study aimed to explore the acceptance of a live chat on familial cancer risk by patients with cancer and their relatives (research question [RQ] 1) and examine the explanatory power of factors associated with their intentions to use such a service (RQ2). Guided by the Extended Unified Theory of Acceptance and Use of Technology (UTAUT2), we examined the explanatory power of the following UTAUT2 factors: performance expectancy, effort expectancy, social influence, facilitating conditions, and habit, supplemented by perceived information insufficiency, perceived susceptibility, perceived severity, and cancer diagnosis as additional factors related to information seeking about familial cancer.We conducted a cross-sectional survey via a German web-based access panel in March 2022 that was stratified by age, gender, and education (N=1084). The participants are or have been diagnosed with cancer themselves (n=144) or have relatives who are or have been affected (n=990). All constructs were measured with established scales. To answer RQ1, descriptive data (mean values and distribution) were used. For RQ2, a blockwise multiple linear regression analysis was conducted.Overall, 32.7% of participants were (rather) willing, 28.9% were undecided, and 38.4% were (rather) not willing to use a live chat on familial cancer risk in the future. A multiple linear regression analysis explained 47% of the variance. It revealed that performance expectancy, social influence, habit, perceived susceptibility, and perceived severity were positively associated with the intention to use a live chat on familial cancer risk. Effort expectancy, facilitating conditions, information insufficiency, and cancer diagnosis were not related to usage intentions.A live chat seems promising for providing information on familial cancer risk. When promoting the service, the personal benefits should be addressed in particular. UTAUT2 is an effective theoretical framework for explaining live chat usage intentions and does not need to be extended in the context of familial cancer risk.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Extended Unified Theory of Acceptance and Use of Technology
|2 Other
650 _ 7 |a cancer information seeking
|2 Other
650 _ 7 |a cancer risk
|2 Other
650 _ 7 |a cross-sectional survey
|2 Other
650 _ 7 |a diagnosis
|2 Other
650 _ 7 |a familial cancer risk
|2 Other
650 _ 7 |a genetic testing
|2 Other
650 _ 7 |a live chat
|2 Other
650 _ 7 |a patients and relatives with cancer
|2 Other
650 _ 7 |a patients with cancer
|2 Other
650 _ 7 |a severity
|2 Other
650 _ 7 |a technology acceptance
|2 Other
700 1 _ |a Baumann, Eva
|0 0000-0002-2357-2138
|b 1
700 1 _ |a Luetke Lanfer, Hanna
|0 0000-0002-3118-248X
|b 2
700 1 _ |a Reifegerste, Doreen
|0 0000-0002-8961-7220
|b 3
700 1 _ |a Geulen, Julia
|0 P:(DE-He78)753065f68c8fb4732728045fb653f044
|b 4
|u dkfz
700 1 _ |a Weber, Winja
|0 P:(DE-He78)8eb7c034317c85ac16b491268dde93d7
|b 5
|u dkfz
700 1 _ |a Hahne, Andrea
|0 0009-0009-9715-4957
|b 6
700 1 _ |a Müller, Anne
|b 7
700 1 _ |a Weg-Remers, Susanne
|0 P:(DE-He78)76dcc66f81ef265e1968a39c42318846
|b 8
|e Last author
|u dkfz
773 _ _ |a 10.2196/45198
|g Vol. 25, p. e45198 -
|0 PERI:(DE-600)2028830-X
|p e45198
|t Journal of medical internet research
|v 25
|y 2023
|x 1439-4456
909 C O |p VDB
|o oai:inrepo02.dkfz.de:282370
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)753065f68c8fb4732728045fb653f044
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)8eb7c034317c85ac16b491268dde93d7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)76dcc66f81ef265e1968a39c42318846
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-04-01T12:45:48Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED INTERNET RES : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T14:53:43Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T14:53:43Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-04-12T14:53:43Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED INTERNET RES : 2022
|d 2023-10-24
920 2 _ |0 I:(DE-He78)M100-20160331
|k M100
|l M100 Krebsinformationsdienst
|x 0
920 1 _ |0 I:(DE-He78)M100-20160331
|k M100
|l M100 Krebsinformationsdienst
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M100-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21